Leap Therapeutics to acquire Pennsylvania biotech in all-stock deal


Leap's stock plummeted Tuesday after the Cambridge-based company announced it acquired Flame Biosciences.

Previous Pickering Energy analysts: Current upstream oil, gas investment cycle only just beginning
Next Preliminary numbers are in for Colorado Option's first year of open enrollment